Cdk5 regulates STAT3 activation and cell proliferation in medullary thyroid carcinoma cells.
about
Cyclin-dependent kinase 5 activity is required for T cell activation and induction of experimental autoimmune encephalomyelitisA cell-based high-content screening assay reveals activators and inhibitors of cancer cell invasionMetabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancerThe role of Cdk5 in neuroendocrine thyroid cancerDifferential expression of cell cycle regulators in CDK5-dependent medullary thyroid carcinoma tumorigenesisGlutathione-S-transferase P1 is a critical regulator of Cdk5 kinase activityRegulation of androgen receptor and prostate cancer growth by cyclin-dependent kinase 5Cyclin-dependent kinase 5 regulates endothelial cell migration and angiogenesis.Co-regulation analysis of closely linked genes identifies a highly recurrent gain on chromosome 17q25.3 in prostate cancerProteomic analysis of the human cyclin-dependent kinase family reveals a novel CDK5 complex involved in cell growth and migrationCDK5 is a major regulator of the tumor suppressor DLC1RNAi screen of the druggable genome identifies modulators of proteasome inhibitor sensitivity in myeloma including CDK5.Study of the Anti-Proliferative Activity of 5-Substituted 4,7-Dimethoxy-1,3-Benzodioxole Derivatives of SY-1 from Antrodia camphorata on Human COLO 205 Colon Cancer CellsCDK5 Regulates Paclitaxel Sensitivity in Ovarian Cancer Cells by Modulating AKT Activation, p21Cip1- and p27Kip1-Mediated G1 Cell Cycle Arrest and Apoptosis.Bioinformatics Knowledge Map for Analysis of Beta-Catenin Function in Cancer.PKA and CDK5 can phosphorylate specific serines on the intracellular domain of podoplanin (PDPN) to inhibit cell motilityCyclin-Dependent Kinase 5 (CDK5) Controls Melanoma Cell Motility, Invasiveness, and Metastatic Spread-Identification of a Promising Novel therapeutic target.Achaete-scute homologue-1 (ASH1) stimulates migration of lung cancer cells through Cdk5/p35 pathway.Retinoic Acid Induces Apoptosis of Prostate Cancer DU145 Cells through Cdk5 OveractivationCdk5-mediated regulation of the PIKE-A-Akt pathway and glioblastoma cell invasionEmodin and Aloe-Emodin Suppress Breast Cancer Cell Proliferation through ER α Inhibition.Evaluation and clinical significance of cyclin-dependent kinase5 expression in cervical lesions: a clinical research study in Guangxi, ChinaPhosphorylation of kinase insert domain receptor by cyclin-dependent kinase 5 at serine 229 is associated with invasive behavior and poor prognosis in prolactin pituitary adenomas.CDK5 and its activator P35 in normal pituitary and in pituitary adenomas: relationship to VEGF expression.The Role of STAT3 in Thyroid Cancer.Epigenetic Component p66a Modulates Myeloid-Derived Suppressor Cells by Modifying STAT3.The Emerging Role of Cdk5 in CancerCyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser⁷²⁷ on STAT3 in prostate cancer cells.Cdk5 links with DNA damage response and cancer.Inhibitory effects of Rhenium-188-labeled Herceptin on prostate cancer cell growth: a possible radioimmunotherapy to prostate carcinoma.The significance of Her2 on androgen receptor protein stability in the transition of androgen requirement in prostate cancer cells.Novel genetic tools reveal Cdk5's major role in Golgi fragmentation in Alzheimer's disease.The cdk5 kinase regulates the STAT3 transcription factor to prevent DNA damage upon topoisomerase I inhibition.The Cdk5/p35 kinases modulate leptin-induced STAT3 signaling.Cyclin-dependent kinase 5 represses Foxp3 gene expression and Treg development through specific phosphorylation of Stat3 at Serine 727Combined Inhibition of Cyclin-Dependent Kinases (Dinaciclib) and AKT (MK-2206) Blocks Pancreatic Tumor Growth and Metastases in Patient-Derived Xenograft Models.TRPV4 plays a role in breast cancer cell migration via Ca2+-dependent activation of AKT and downregulation of E-cadherin cell cortex protein.Cdk5 controls IL-2 gene expression via repression of the mSin3a-HDAC complex.Effects of roniciclib in preclinical models of anaplastic thyroid cancer.Involvement of cAMP in nerve growth factor-triggered p35/Cdk5 activation and differentiation in PC12 cells.
P2860
Q24623805-E34A8B4F-81A6-462D-BBFC-6837D7DB9A70Q24627610-5BED37FE-F801-42E5-A867-204835D572B5Q28072669-F5BEF912-FB07-4B47-A4FE-AE6CC69B2C72Q28392185-BE7A7D5D-F68C-47F4-BC59-D203546BD9EBQ28397935-9DA7ACC6-9769-4DF9-8C34-D21FFA192150Q28565510-0995B63F-9F2A-4804-8BDC-B4635D1A1F4DQ30424897-38ED2D08-8B98-4376-A29C-E10425368267Q30497293-95E65D5F-0763-40B2-8166-35E5835ED2ACQ33381372-B85F6DF2-A958-4B50-A38F-695871EB3767Q34468337-EC2472EF-9683-47E4-B4E4-3A03B4C184ABQ34656836-F49C4A27-63E4-48A7-B628-D2A6A01D1D97Q34870566-3800AE47-200D-4021-9CF1-9FDE04CE9DDDQ35111567-F9B0A727-9EB7-4E14-931D-B7377BFD979EQ35683173-BFA5207B-D46E-49B8-93B4-3D8F9F45B9D0Q35824062-F45C7623-76BB-4FCD-B350-E49F05034F9CQ36015517-81C28C39-BDD3-49E7-B323-9083AC4873F2Q36037996-D90FFCF5-2C7D-48F4-8F4C-50A9E85D72CEQ36127961-78DE8CF1-3BAD-4DFE-85AC-EC0D5A518FA3Q36495910-A339911D-6BD0-48E2-913D-AC04F9E653ABQ36677119-13FABAD9-AC68-467F-BECE-AD8C801C6877Q36999345-F2D83ACD-A61F-4865-AF0E-B9D06575FCD7Q37089878-6C6AE463-BDAF-4123-8F13-63EF2FE80827Q37588211-69E7D073-613A-4266-8D15-BBCD356FA6CEQ37589653-01290FA6-2EBA-4B85-BB1E-3ACAE3502B30Q37693498-5B00FADE-4178-4207-B26E-64FB29FEC6F4Q38963271-96C843C0-4E86-48A8-A5CB-32CFEABB2765Q39029140-86935D3C-55E2-478B-B8F3-C9C5290FD5B8Q39110728-6087F778-F8F1-44DB-8AB6-9625E7B8C7FCQ39176295-352EA7DE-4093-43C5-AFAE-273FEAA49944Q39215370-1730C32F-EFEA-42B2-A3E6-B4A4859A137CQ39583643-09F2A206-30B1-4CB9-AB70-16C85B4FE3A6Q39630367-D670FB72-F7D1-47D8-A77B-A33C39BE5727Q39697762-E39D5B5D-C8D7-4A10-ACA0-518236DF214CQ39892992-36D79969-E230-4708-9A05-DB8FD7D255E4Q40710775-6DACA027-F953-440C-B1A4-FF395EC97DA6Q40989800-B3240C88-D56A-4F6F-A00C-34002D377B32Q41098513-0527A87B-F533-4D2D-81CB-D306A8773F9FQ41198721-CF8D9EAF-2093-4C50-B85A-0CE2E60D25A3Q42366591-CA9910D4-8506-4561-8FDC-EE6FEBAB2880Q43654475-FC361E5C-46E1-48C0-9490-AA3B413D78A5
P2860
Cdk5 regulates STAT3 activation and cell proliferation in medullary thyroid carcinoma cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Cdk5 regulates STAT3 activatio ...... llary thyroid carcinoma cells.
@en
type
label
Cdk5 regulates STAT3 activatio ...... llary thyroid carcinoma cells.
@en
prefLabel
Cdk5 regulates STAT3 activatio ...... llary thyroid carcinoma cells.
@en
P2093
P2860
P356
P1476
Cdk5 regulates STAT3 activatio ...... llary thyroid carcinoma cells.
@en
P2093
Chih-Yuan Chiu
Mei-Chih Chen
Shih-Yi Lin
Yuh-Min Song
P2860
P304
P356
10.1074/JBC.M607234200
P407
P577
2006-12-04T00:00:00Z